Adjuvant toripalimab for locally advanced head and neck squamous cell carcinoma patients who achieved pathological complete response after neoadjuvant immunochemotherapy and surgery: A single-arm, phase II trial

被引：0
|
作者：
Chen, S. [1 ]
Yan, S. [1 ]
Hu, W. [2 ]
Lin, Q. [1 ]
Zhou, J. [3 ]
Chen, W. [1 ]
Liu, X. [1 ]
Guo, Z. [1 ]
Zhang, X. [1 ]
Yang, C. [1 ]
Gao, X. [1 ]
Li, M. [1 ]
Li, X. [1 ]
Zhang, S. [1 ]
Zhang, Y. [1 ]
Zhang, Q. [1 ]
Yang, A. [1 ]
Song, M. [1 ]
机构：
[1] Sun Yat Sen Univ Canc Ctr, Dept Head & Neck Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Dept Pathol, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ Canc Ctr, Radiol, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.927
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
865P
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial
    Huang, Jiwei
    Wang, Yueming
    Xu, Fan
    Wang, Zaoyu
    Wu, Guangyu
    Kong, Wen
    Cheoklong, Ng
    Tricard, Thibault
    Wu, Xiaorong
    Zhai, Wei
    Zhang, Wei
    Zhang, Jiyang
    Zhang, Ding
    Chen, Shuyin
    Lian, Yuqing
    Chen, Yonghui
    Zhang, Jin
    Huang, Yiran
    Xue, Wei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (06)
  • [2] NEOADJUVANT TORIPALIMAB COMBINED WITH AXITINIB IN PATIENTS WITH LOCALLY ADVANCED CLEAR CELL RENAL CELL CARCINOMA: A SINGLE-ARM, PHASE II TRIAL
    Huang, Jiwei
    JOURNAL OF UROLOGY, 2024, 211 (05): : E712 - E713
  • [3] Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial
    Zhang, Zhanjie
    Wu, Bian
    Peng, Gang
    Xiao, Guixiang
    Huang, Jing
    Ding, Qian
    Yang, Chengzhang
    Xiong, Xingao
    Ma, Hui
    Shi, Liangliang
    Yang, Jinsong
    Hong, Xiaohua
    Wei, Jielin
    Qin, You
    Wan, Chao
    Zhong, Yi
    Zhou, Yan
    Zhao, Xueyan
    Leng, Yangming
    Zhang, Tao
    Wu, Gang
    Yao, Min
    Zhang, Xiaomeng
    Yang, Kunyu
    CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3268 - 3276
  • [4] Preoperative neoadjuvant chemoimmunotherapy for locally advanced head and neck squamous cell carcinoma patients: A prospective, single-arm, phase II clinical study
    Han, P.
    Huang, X.
    Liang, F.
    Lin, P.
    Chen, R.
    Wu, T.
    Li, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S619 - S619
  • [5] Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)
    Huang, Yingying
    Sun, Jingjing
    Li, Jun
    Zhu, Dongwang
    Dong, Minjun
    Dou, Shengjin
    Tang, Yong
    Shi, Wentao
    Sun, Qi
    Zhao, Tongchao
    Zhou, Zhihang
    Zhou, Xinyu
    Liu, Ying
    Li, Jiang
    Zhu, Guopei
    Zhang, Ding
    Chen, Yanan
    Zhu, Qi
    Ju, Wutong
    Zhong, Laiping
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (08) : 2220 - 2227
  • [6] Neoadjuvant tislelizumab combined with APF for patients with locally advanced head and neck squamous cell carcinoma: A prospective single-arm clinical trial
    Yan, Jing
    Wang, Kong-cheng
    Yang, Mi
    Gu, Ya-Jun
    Huang, Bin
    Zhu, Yahui
    Sha, Hui-zi
    Zhu, Jing
    Zhu, Chan
    Chen, Dong-sheng
    Qian, Xiao-Yun
    Shen, Xiao-hui
    Chen, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Neoadjuvant pembrolizumab/nab-paclitaxel/cisplatin in patients with locally advanced head and neck squamous cell carcinoma: A single-arm phase II study
    Zhang, Siyi
    Ma, Haiqing
    Zhan, Jiandong
    Zhu, Lijun
    Zhang, Hong-Dan
    Du, Shasha
    Dong, Qiumei
    Wang, Guangyi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial
    Ou, Dan
    Cai, Rong
    Qi, Wei-Xiang
    Cui, Can
    Cao, Lu
    Wang, Shu-Bei
    Li, Huan
    Ma, Tao
    Miao, Ying
    Xu, Cheng
    Cai, Gang
    Cao, Wei-Guo
    Gao, Yun-Sheng
    Chen, Jia-Yi
    Xu, Hao-Ping
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [9] Neoadjuvant tislelizumab plus chemotherapy followed by salvage surgery and adjuvant tislelizumab for recurrent head and neck squamous cell carcinoma after radiotherapy: A single-arm, phase II trial
    Wu, Wenjie
    Wang, Lin
    Zhang, Tong
    Zhang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial
    Huang, Xiaotao
    Liu, Qiaodan
    Zhong, Guihua
    Peng, Yingpeng
    Liu, Ye
    Liang, Lizhong
    Hong, Haiyu
    Feng, Weineng
    Yang, Shuang
    Zhang, Yaqin
    Xian, Shiping
    Li, Zhanyu
    Zhou, Yuling
    Zhang, Zhaoyuan
    Jiang, Wen
    Liang, Jun
    Liu, Zhi-gang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
12345